メインコンテンツにスキップ
検索

The report highlights a commitment to sustainability and corporate responsibilities.

RADNOR, Pa. – 2025年8月26日 – Certara, Inc. バイオシミュレーションのグローバルリーダーであるサターラ(Nasdaq:CERT) はCERT), a global leader in model-informed drug development (MIDD), today announced that it has issued its 2025 environmental, social, and governance (ESG) report. The report outlines Certara’s approach to a responsible ESG framework across three strategic priorities: accelerating crucial medicines to patients, advancing scientific thought leadership and knowledge sharing, and increasing engagement with employees.

“Certara is transforming the way new medicines are discovered and developed helping bring treatments to patients faster and more efficiently,” said Daniel Corcoran, Senior Vice President and General Counsel. “We achieve this by delivering world-class biosimulation science and solutions to our clients, while also holding ourselves accountable to strong environmental, social, and governance practices. "

Certara 2025 ESG Report Highlights

  • Introduced 36 new software applications and upgrades with R&D investment of $37.1M (9% of revenue) in 2024.
  • Collaborated on more than 9,000 customer projects in the last decade.
  • Supported 300+ regulatory submissions in the past 5 years.
  • Total market-based greenhouse gas emissions were reduced by 21.51%*.
  • Fortune Best Workplaces in Biopharma 2022-2024 Great Place to Work® 2022-2025
  • Fortune Best Workplaces in the New York region 2024 (including PA, NJ, and CT)

Certara’s ESG Report is available here. The ESG Report was published in August 2025 and reflects data and information as of the respective dates set forth therein.

*Measures were captured and reported by an external sustainability advisor from 2023 to 2024. Emissions measures are Scopes 1 through 3, including direct, upstream and downstream measures.

Certara(サターラ)について

サターラは、モデリング&シミュレーション・ソフトウェアと技術を用いて、従来の創薬・開発を変革し、医薬品をよりスピーディーに患者さんに届けることをミッションとしています。製薬、教育機関、規制当局のお客様 2,400人以上、70ヵ国にてサターラの技術やサービスが活用されています。詳細は弊社ホームページをご覧ください。

サターラの問い合わせ先:

Sheila Rocchio
[email protected]

報道機関の皆様:

赤津笑美 (emi.akatsu@certara.com)
[email protected]

Powered by Translations.com GlobalLink Web Software